Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Nov 14, 2022 1:26am
296 Views
Post# 35095751

#9 at Health Canada + 7 others with * priority so TBP = #16

#9 at Health Canada + 7 others with * priority so TBP = #16 Reduvo and Tetra ARE NOT a priority at Health Canada .....There are 7 others with * symbols,  they have priority so there are 7 priority covid related, (read the bottom of the Health Canada page)  Tetra in  # 9 spot now , add another 7 so it is number 16 at best maybe check back in March 2023 , maybe also go back and look at the notes from 2017 and 2018 where Guys private company 9315446 Quebec Inc. owns 20% a sub. company that Tetra owns .
Intelgenx is working on the Dronabinol and doing the research for Tetra , once again Guy is just the general contractor here moving shareholders money around and has millions in payments due to them if Reduvo is approved. . Health Canada seems to approve 2 a month so IT COULD BE ANOTHER 8 MONTHS !
Too much debt almost 140,000,000 ...Demand loans at 15% , thanks Guy .Reduvo will not save Tetra and Guy will sell it off to keep his wage going and feed his private numbered company going . He can't even communicate with updates or any real  information to shareholders, so buy all you can because the next sales pitch Guy is going to give shareholders is a reverse split or he goes bankrupt and gives the company to Panag Pharma a privately held sub company for the bad deals and money he owes them and cannot pay, if Tetra goes bankrupt there is a 10,000,000 payment due to Panag Pharma either way he wins and we the shareholders lose. I am just fed up with him getting rich while shareholders have lost so much here and keep paying him.

<< Previous
Bullboard Posts
Next >>